Discover undervalued stocks with Eulerpool.

Subscribe for $2

Shengtai Pharmaceutical Stock SGTI

Price

0
Today +/-
-0
Today %
-0 %

Shengtai Pharmaceutical stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Shengtai Pharmaceutical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Shengtai Pharmaceutical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Shengtai Pharmaceutical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Shengtai Pharmaceutical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Shengtai Pharmaceutical Stock Price History

DateShengtai Pharmaceutical Price
12/11/20230 undefined
12/10/20230.00 undefined
2/5/20230.00 undefined

Shengtai Pharmaceutical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shengtai Pharmaceutical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shengtai Pharmaceutical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shengtai Pharmaceutical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shengtai Pharmaceutical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shengtai Pharmaceutical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shengtai Pharmaceutical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shengtai Pharmaceutical’s growth potential.

Shengtai Pharmaceutical Revenue, EBIT and net profit per share

DateShengtai Pharmaceutical RevenueShengtai Pharmaceutical EBITShengtai Pharmaceutical Net Income
2012179.03 M undefined5.5 M undefined1.07 M undefined

Shengtai Pharmaceutical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (k)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
2012
179
-
9.50
17
1,000
-
9.58
-
Details

Keystats

ⓘ

Revenue and Growth

The Shengtai Pharmaceutical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Shengtai Pharmaceutical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (k)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (k)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
2012
 
4.9
12.1
13.45
29.46
14.11
74.02
81.4
11.7
0
3.27
0
2.19
98.56
172.59
 
9.6
21.95
31.29
9.09
0
62.33
5.84
479.6
12.32
91.61
0
110.25
0
0
0
0
110.25
172.59
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Shengtai Pharmaceutical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Shengtai Pharmaceutical's financial health and stability.

Assets

Shengtai Pharmaceutical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Shengtai Pharmaceutical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Shengtai Pharmaceutical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Shengtai Pharmaceutical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
2012
1,000
8
0
-32
0
4
0
-23
0
-1
-1
0
30
0
26
-4.00
0
0
-23.87
0

Shengtai Pharmaceutical stock margins

The Shengtai Pharmaceutical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shengtai Pharmaceutical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shengtai Pharmaceutical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shengtai Pharmaceutical's sales revenue. A higher gross margin percentage indicates that the Shengtai Pharmaceutical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shengtai Pharmaceutical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shengtai Pharmaceutical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shengtai Pharmaceutical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shengtai Pharmaceutical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shengtai Pharmaceutical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shengtai Pharmaceutical Margin History

Shengtai Pharmaceutical Gross marginShengtai Pharmaceutical Profit marginShengtai Pharmaceutical EBIT marginShengtai Pharmaceutical Profit margin
20129.68 %3.07 %0.6 %

Shengtai Pharmaceutical Stock Sales Revenue, EBIT, Earnings per Share

The Shengtai Pharmaceutical earnings per share therefore indicates how much revenue Shengtai Pharmaceutical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shengtai Pharmaceutical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shengtai Pharmaceutical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shengtai Pharmaceutical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shengtai Pharmaceutical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shengtai Pharmaceutical Revenue, EBIT and net profit per share

DateShengtai Pharmaceutical Sales per ShareShengtai Pharmaceutical EBIT per shareShengtai Pharmaceutical Earnings per Share
201218.68 undefined0.57 undefined0.11 undefined

Shengtai Pharmaceutical business model

Shengtai Pharmaceutical Inc is a Chinese company specializing in the manufacturing and distribution of pharmaceuticals and medications. It was founded in 1995 and is headquartered in the city of Weihai in Shandong province. The company's history began as a small local pharmacy operated by a man named Liu Wenqing. Over the years, the business expanded and became one of the leading pharmaceutical companies in China. Shengtai Pharmaceutical's business model is based on the production and sale of prescription and over-the-counter drugs. The company operates in four main areas: active pharmaceutical ingredients, finished pharmaceuticals, animal health, and dietary supplements. In the active pharmaceutical ingredients segment, Shengtai manufactures pharmaceutical ingredients used in the production of various medical products. These substances are sold both domestically and internationally. The company has supply contracts with numerous multinational pharmaceutical companies and is also capable of conducting its own research and development. The finished pharmaceuticals produced by Shengtai Pharmaceutical primarily include medications for the treatment of cardiovascular diseases, diabetes, and gastrointestinal diseases. The company has an extensive product line with over 300 medications. Additionally, the company also has a business focus in the field of animal health. Here, Shengtai develops and distributes pharmaceutical products targeting animal owners in the agriculture and pet care sectors. These products include vaccines, anti-parasitic drugs, and antibiotics. Dietary supplements are another area in which Shengtai Pharmaceutical is active. The company manufactures a variety of dietary supplements containing vitamins, minerals, enzymes, and other nutrients aimed at supporting health maintenance and improving well-being. Shengtai Pharmaceutical is a company that offers many different products in the market and operates in various areas. The company has earned a good reputation over the years and is known for its high product quality and strong customer orientation. The company has a strong presence in China and is also increasingly internationally focused. Shengtai Pharmaceutical relies on continuous innovation and state-of-the-art technologies to maximize the effectiveness and safety of its products. In conclusion, Shengtai Pharmaceutical Inc is an important player in the Chinese pharmaceutical industry, offering a variety of products and services and placing a high emphasis on research and development and innovation. Shengtai Pharmaceutical is one of the most popular companies on Eulerpool.com.

Shengtai Pharmaceutical SWOT Analysis

Strengths

Shengtai Pharmaceutical Inc boasts a strong manufacturing infrastructure, enabling efficient production processes and cost advantages. With an established reputation in the industry, the company maintains a loyal customer base. The company's extensive product portfolio provides diversification and the ability to cater to various market segments. Shengtai Pharmaceutical Inc's commitment to quality control ensures consistent product excellence.

Weaknesses

Shengtai Pharmaceutical Inc currently faces limitations in its market reach due to a narrower distribution network compared to some competitors. The company's heavy reliance on a specific geographic region or market segment might pose risks in times of economic fluctuations or regulatory changes.

Opportunities

The rising global demand for pharmaceutical products presents substantial growth opportunities for Shengtai Pharmaceutical Inc. Exploring untapped markets and geographical expansion can further enhance the company's market share. Shengtai Pharmaceutical Inc can also leverage emerging technology to streamline operations, improve research and development capabilities, and introduce innovative products.

Threats

Shengtai Pharmaceutical Inc operates in an intensely competitive industry where new entrants and established competitors constantly vie for market share. The company must stay vigilant in monitoring changing regulations and compliance requirements to avoid any legal issues. Fluctuations in raw material prices, currency exchange rates, and economic conditions can affect profitability.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Shengtai Pharmaceutical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Shengtai Pharmaceutical historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Shengtai Pharmaceutical shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shengtai Pharmaceutical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shengtai Pharmaceutical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shengtai Pharmaceutical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shengtai Pharmaceutical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shengtai Pharmaceutical stock splits

In Shengtai Pharmaceutical's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Shengtai Pharmaceutical.

Shengtai Pharmaceutical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20080.14 -0.04  (-128.01 %)2009 Q2
9/30/20080.23 0.06  (-74.42 %)2009 Q1
6/30/20080.22 0.32  (42.6 %)2008 Q4
3/31/20080.16 0.2  (22.55 %)2008 Q3
1

Shengtai Pharmaceutical Executives and Management Board

Qingtai Liu

(55)
Shengtai Pharmaceutical Chairman of the Board, Chief Executive Officer
Compensation 19,004

Yongqiang Wang

(43)
Shengtai Pharmaceutical Chief Financial Officer, Director (since 2007)
Compensation 14,253

Tao Jin

(44)
Shengtai Pharmaceutical Independent Director

Mr. Lawrence Lee

(50)
Shengtai Pharmaceutical Independent Director

Yaojun Liu

(36)
Shengtai Pharmaceutical Independent Director
1

Most common questions regarding Shengtai Pharmaceutical

What values and corporate philosophy does Shengtai Pharmaceutical represent?

Shengtai Pharmaceutical Inc represents a dedication to excellence and integrity in the pharmaceutical industry. The company's core values include innovation, quality, and customer satisfaction. With a strong emphasis on research and development, Shengtai Pharmaceutical Inc aims to provide cutting-edge healthcare solutions to improve people's lives. The company's corporate philosophy centers around ethical business practices, sustainability, and social responsibility. Shengtai Pharmaceutical Inc strives to deliver safe and effective pharmaceutical products while maintaining transparency and trust with its stakeholders. Overall, Shengtai Pharmaceutical Inc embodies a commitment to high standards and the well-being of its customers and communities.

In which countries and regions is Shengtai Pharmaceutical primarily present?

Shengtai Pharmaceutical Inc is primarily present in China, where it operates its main facilities and serves as a leading pharmaceutical company. With a strong domestic presence, Shengtai Pharmaceutical Inc has established a solid reputation for its high-quality products and innovative pharmaceutical solutions. While focused on the Chinese market, the company also exports its products to various countries and regions worldwide, including Europe, North America, Asia-Pacific, and Africa. Shengtai Pharmaceutical Inc's global reach allows it to cater to a diverse range of customers and expand its international footprint.

What significant milestones has the company Shengtai Pharmaceutical achieved?

Shengtai Pharmaceutical Inc has achieved several significant milestones. Firstly, the company successfully listed on the New York Stock Exchange (NYSE) in 2007, enabling greater access to capital markets and investors. Additionally, Shengtai Pharmaceutical has expanded its product portfolio, focusing on the research and development of innovative pharmaceuticals and biological products. The company has also made noteworthy progress in international collaborations and strategic partnerships, enhancing its global presence. Furthermore, Shengtai Pharmaceutical has consistently strived for excellence by adhering to stringent quality standards and obtaining certifications such as the Good Manufacturing Practice (GMP) license. Overall, Shengtai Pharmaceutical Inc has experienced commendable growth and established itself as a reputable player in the pharmaceutical industry.

What is the history and background of the company Shengtai Pharmaceutical?

Shengtai Pharmaceutical Inc is a leading pharmaceutical company with a rich history and background. Founded in 1995, the company has been committed to providing high-quality healthcare products and services to customers worldwide. With its headquarters in China, Shengtai Pharmaceutical Inc has established a strong presence in the global market, focusing on the research, development, and production of various pharmaceutical products. The company's dedication to innovation, coupled with its state-of-the-art facilities and highly skilled workforce, has contributed to its success in offering a wide range of medicines and therapeutic solutions. Shengtai Pharmaceutical Inc continues to strive for excellence in improving global healthcare and making a positive impact on people's lives.

Who are the main competitors of Shengtai Pharmaceutical in the market?

The main competitors of Shengtai Pharmaceutical Inc in the market include companies such as China Grand Pharmaceutical and Healthcare Holdings Limited, Livzon Pharmaceutical Group Inc., and Shanghai Fosun Pharmaceutical Group Co., Ltd.

In which industries is Shengtai Pharmaceutical primarily active?

Shengtai Pharmaceutical Inc is primarily active in the pharmaceutical industry.

What is the business model of Shengtai Pharmaceutical?

The business model of Shengtai Pharmaceutical Inc revolves around the manufacturing and selling of pharmaceutical products in China. The company primarily focuses on the production of traditional Chinese medicines, such as herbal medicines and botanical extracts. Shengtai Pharmaceutical Inc aims to provide high-quality and effective healthcare solutions to customers by utilizing advanced technologies and adhering to strict quality standards. With a strong commitment to research and development, Shengtai Pharmaceutical Inc continuously strives to expand its product portfolio and improve overall wellness.

What is the P/E ratio of Shengtai Pharmaceutical 2025?

The P/E ratio cannot be calculated for Shengtai Pharmaceutical at the moment.

What is the P/S ratio of Shengtai Pharmaceutical 2025?

The P/S cannot be calculated for Shengtai Pharmaceutical currently.

What is the Quality Investing of Shengtai Pharmaceutical?

The Quality Investing cannot be calculated for Shengtai Pharmaceutical at the moment.

What is the revenue of Shengtai Pharmaceutical 2025?

The revenue cannot currently be calculated for Shengtai Pharmaceutical.

How high is the profit of Shengtai Pharmaceutical 2025?

The profit cannot currently be calculated for Shengtai Pharmaceutical.

What is the business model of Shengtai Pharmaceutical

Shengtai Pharmaceutical Inc is a leading company in the field of pharmaceutical manufacturing and marketing. The company is headquartered in Shandong, China and has multiple branches worldwide, including in North America, Europe, and Southeast Asia. Shengtai Pharmaceutical Inc offers a wide range of products and services, divided into several core areas, to effectively meet the needs of its customers. Research and Development Shengtai Pharmaceutical Inc invests heavily in research and development to produce a wide range of pharmaceutical products that meet high quality and safety standards. The company employs a team of researchers and scientists who constantly research and develop new medical compounds, formulas, and therapies. The company utilizes cutting-edge technologies and strategic partnerships to provide its customers with effective, safe, and innovative products. Pharmaceutical Production Shengtai Pharmaceutical Inc owns and operates production facilities in China, the USA, and Europe. The production facilities are equipped with state-of-the-art equipment and technologies used in the manufacturing of high-quality pharmaceutical products. Compliance with GMP standards is of utmost importance at Shengtai Pharmaceutical Inc to ensure the highest efficacy and safety of its products. Marketing and Distribution Shengtai Pharmaceutical Inc has established a strong sales and marketing network worldwide to effectively market and distribute its products. The company works closely with distribution partners and retailers to directly deliver products to end consumers. Shengtai Pharmaceutical Inc also utilizes e-commerce platforms to reach a wider customer base and serve its customers around the world. Products from Shengtai Pharmaceutical Inc Shengtai Pharmaceutical Inc offers a wide range of products divided into various segments. The segments include neuropathy, anti-infectives, pain management, antihistamines, cardiovascular and respiratory medicine, as well as medicines for treating diabetes, thyroid problems, and cancer. Some of the well-known products from Shengtai Pharmaceutical Inc include Cefprozil tablets, Levetiracetam capsules, Azacitidine injections, and Fentanyl transdermal patches. In summary, the business model of Shengtai Pharmaceutical Inc is based on research and development, pharmaceutical production, and marketing and distribution of pharmaceutical products. The company offers a wide range of products divided into various categories to meet the needs of its customers. Compliance with GMP standards and adherence to the highest quality and safety standards have helped establish Shengtai Pharmaceutical Inc as a trusted and reliable provider of pharmaceutical products in the industry.

What is the Shengtai Pharmaceutical dividend?

Shengtai Pharmaceutical pays a dividend of 0 USD distributed over payouts per year.

How often does Shengtai Pharmaceutical pay dividends?

The dividend cannot currently be calculated for Shengtai Pharmaceutical or the company does not pay out a dividend.

What is the Shengtai Pharmaceutical ISIN?

The ISIN of Shengtai Pharmaceutical is US8232142005.

What is the Shengtai Pharmaceutical WKN?

The WKN of Shengtai Pharmaceutical is A1C9DZ.

What is the Shengtai Pharmaceutical ticker?

The ticker of Shengtai Pharmaceutical is SGTI.

How much dividend does Shengtai Pharmaceutical pay?

Over the past 12 months, Shengtai Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Shengtai Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of Shengtai Pharmaceutical?

The current dividend yield of Shengtai Pharmaceutical is .

When does Shengtai Pharmaceutical pay dividends?

Shengtai Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Shengtai Pharmaceutical?

Shengtai Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Shengtai Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Shengtai Pharmaceutical located?

Shengtai Pharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shengtai Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shengtai Pharmaceutical from 10/14/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/14/2025.

When did Shengtai Pharmaceutical pay the last dividend?

The last dividend was paid out on 10/14/2025.

What was the dividend of Shengtai Pharmaceutical in the year 2024?

In the year 2024, Shengtai Pharmaceutical distributed 0 USD as dividends.

In which currency does Shengtai Pharmaceutical pay out the dividend?

The dividends of Shengtai Pharmaceutical are distributed in USD.

All fundamentals about Shengtai Pharmaceutical

Our stock analysis for Shengtai Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shengtai Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.